See also: Generic Humalog KwikPen, Generic Humalog Pen
Humalog is a brand name of insulin lispro, approved by the FDA in the following formulation(s):
HUMALOG (insulin lispro recombinant - injectable; injection)
Manufacturer: LILLY
Approval date: June 14, 1996
Strength(s): 100 UNITS/ML [RLD]
Has a generic version of Humalog been approved?
No. There is currently no therapeutically equivalent version of Humalog available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Humalog. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
Insulin analog formulations
Patent 5,474,978
Issued: December 12, 1995
Inventor(s): Bakaysa; Diane L. & Brems; David N. & Frank; Bruce H. & Havel; Henry A. & Pekar; Allen H.
Assignee(s): Eli Lilly and Company
The present invention discloses a human insulin analog hexamer complex and formulations. More specifically, the present invention relates to various parenteral formulations, which comprise: human insulin analogs in a hexamer conformation, zinc ions, and at least three molecules of a phenolic derivative selected from the group consisting of m-cresol, phenol, or a mixture of m-cresol and phenol. The formulation provides a rapid onset of action.Patent expiration dates:
- June 16, 2014✓
- June 16, 2014
Insulin analogs modified at position 29 of the B chain
Patent 5,514,646
Issued: May 7, 1996
Inventor(s): Chance; Ronald E. & DiMarchi; Richard D. & Frank; Bruce H. & Shields; James E.
Analogs of human insulin modified at position 29 of the B chain thereof and, optionally, at other positions, have modified physico-chemical and pharmacokinetic properties and are useful in the treatment of hyperglycemia.Patent expiration dates:
- May 7, 2013✓
- May 7, 2013
See also...
- Humalog Consumer Information (Drugs.com)
- Humalog Cartridges Consumer Information (Wolters Kluwer)
- Humalog Vials Consumer Information (Wolters Kluwer)
- Humalog Consumer Information (Cerner Multum)
- Humalog Advanced Consumer Information (Micromedex)
- Humalog AHFS DI Monographs (ASHP)
- Insulin Lispro Cartridges Consumer Information (Wolters Kluwer)
- Insulin Lispro Vials Consumer Information (Wolters Kluwer)
- Insulin lispro Consumer Information (Cerner Multum)
- Lispro-PFC Advanced Consumer Information (Micromedex)
- Insulin lispro Subcutaneous Advanced Consumer Information (Micromedex)
- Insulin lispro, recombinant Subcutaneous Advanced Consumer Information (Micromedex)
- Insulin Lispro AHFS DI Monographs (ASHP)
